#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer Retinitis pigmentosa Non-Hodgkin's lymphoma refractory Astrocytoma Carcinoid tumour Pulmonary sarcoidosis Oesophageal achalasia Haemophilia B without inhibitors Pulmonary fibrosis Palmar-plantar erythrodysaesthesia syndrome Infantile spasms Arterial disorder Autoimmune myositis Duchenne muscular dystrophy gene carrier Growth hormone deficiency More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Activated PI3 kinase delta syndrome – Treatment Undifferentiated sarcoma – Diagnostics Systemic sclerosis pulmonary – Diagnostics Progressive supranuclear palsy – Diagnostics Short-bowel syndrome – Diagnostics Nephrotic syndrome Paraneoplastic neurological syndrome – Life with Disease Burkitt’s lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Salmeterol Xinafoate Oxazepam Mrna-3210 Vincristine Magrolimab Gelatin Charcoal, Activated Bay 2927088 Calcium Polystyrene Sulfonate Neratinib Florquinitau (18F) Memantine Hydrochloride Kan-101 Phentermine Viltolarsen Sitravatinib Malate Bi 1015550 MALIC ACID NORETHISTERONE ACETATE Goserelin Acetate More therapies…

    Learn about Your Condition

    Optic glioma Hypoparathyroidism Red blood cell abnormality Pouchitis Sarcoma Cerebellar ataxia Genital herpes simplex Pustular psoriasis Cutaneous sarcoidosis Hysterectomy Penile squamous cell carcinoma Astrocytoma malignant Psoriatic arthropathy Liposarcoma B-cell type acute leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Rilvegostomig
    • Datopotamab Deruxtecan
    • Infliximab
    Austria Belgium Germany Hungary Italy Poland +1

  • Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine with aura
    • Migraine without aura
    • Migraine
    Investigated Drugs:
    • Rimegepant
    Poland Spain

  • Long-Term Safety Study of GLM101 for Patients with PMM2-CDG

    Recruiting

    2 1 1
    Investigated Diseases:
    • Metabolic disorder
    Investigated Drugs:
    • M1P Dipotassium Salt
    Czechia France Germany Italy Portugal Spain

  • Study Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Methylprednisolone
    • Sirolimus
    Norway

  • Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Central nervous system neuroblastoma
    • Neuroblastoma
    Investigated Drugs:
    • Human Albumin Solution
    • Water For Injection
    • Glucose
    Austria France Germany Italy The Netherlands Poland +1

  • Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Mdna11
    • Pembrolizumab
    Ireland Poland Portugal Spain
Previous Page
1 … 509 510 511 512 513 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!